Cyclosporine-associated renal dysfunction in marrow transplant recipients

Gary C Yee, M. S. Kennedy, H. J. Deeg, T. M. Leonard, E. D. Thomas, R. Storb

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

CsA is a major contributing factor in the development of posttransplant renal dysfunction in marrow transplant patients. The wide interpatient variability in CsA concentration (Fig 3), the narrow therapeutic index of CsA, and the significant correlation between CsA concentration and renal dysfunction suggest that monitoring of trough CsA concentrations may be helpful in minimizing unnecessary renal toxicity, at least in marrow transplant recipients. Further studies are needed to determine whether CsA concentration correlates with prevention of graft-v-host disease. Co-administration of potentially nephrotoxic drugs during CsA therapy should be avoided or minimized if possible.

Original languageEnglish (US)
Pages (from-to)196-201
Number of pages6
JournalTransplantation Proceedings
Volume17
Issue number4 SUPPL. 1
StatePublished - Dec 1 1985

Fingerprint

Cyclosporine
Bone Marrow
Kidney
Transplants
Therapeutics
Pharmaceutical Preparations
Transplant Recipients

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Yee, G. C., Kennedy, M. S., Deeg, H. J., Leonard, T. M., Thomas, E. D., & Storb, R. (1985). Cyclosporine-associated renal dysfunction in marrow transplant recipients. Transplantation Proceedings, 17(4 SUPPL. 1), 196-201.

Cyclosporine-associated renal dysfunction in marrow transplant recipients. / Yee, Gary C; Kennedy, M. S.; Deeg, H. J.; Leonard, T. M.; Thomas, E. D.; Storb, R.

In: Transplantation Proceedings, Vol. 17, No. 4 SUPPL. 1, 01.12.1985, p. 196-201.

Research output: Contribution to journalArticle

Yee, GC, Kennedy, MS, Deeg, HJ, Leonard, TM, Thomas, ED & Storb, R 1985, 'Cyclosporine-associated renal dysfunction in marrow transplant recipients', Transplantation Proceedings, vol. 17, no. 4 SUPPL. 1, pp. 196-201.
Yee GC, Kennedy MS, Deeg HJ, Leonard TM, Thomas ED, Storb R. Cyclosporine-associated renal dysfunction in marrow transplant recipients. Transplantation Proceedings. 1985 Dec 1;17(4 SUPPL. 1):196-201.
Yee, Gary C ; Kennedy, M. S. ; Deeg, H. J. ; Leonard, T. M. ; Thomas, E. D. ; Storb, R. / Cyclosporine-associated renal dysfunction in marrow transplant recipients. In: Transplantation Proceedings. 1985 ; Vol. 17, No. 4 SUPPL. 1. pp. 196-201.
@article{1374274c7b3846009c378acfe85c5e90,
title = "Cyclosporine-associated renal dysfunction in marrow transplant recipients",
abstract = "CsA is a major contributing factor in the development of posttransplant renal dysfunction in marrow transplant patients. The wide interpatient variability in CsA concentration (Fig 3), the narrow therapeutic index of CsA, and the significant correlation between CsA concentration and renal dysfunction suggest that monitoring of trough CsA concentrations may be helpful in minimizing unnecessary renal toxicity, at least in marrow transplant recipients. Further studies are needed to determine whether CsA concentration correlates with prevention of graft-v-host disease. Co-administration of potentially nephrotoxic drugs during CsA therapy should be avoided or minimized if possible.",
author = "Yee, {Gary C} and Kennedy, {M. S.} and Deeg, {H. J.} and Leonard, {T. M.} and Thomas, {E. D.} and R. Storb",
year = "1985",
month = "12",
day = "1",
language = "English (US)",
volume = "17",
pages = "196--201",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "4 SUPPL. 1",

}

TY - JOUR

T1 - Cyclosporine-associated renal dysfunction in marrow transplant recipients

AU - Yee, Gary C

AU - Kennedy, M. S.

AU - Deeg, H. J.

AU - Leonard, T. M.

AU - Thomas, E. D.

AU - Storb, R.

PY - 1985/12/1

Y1 - 1985/12/1

N2 - CsA is a major contributing factor in the development of posttransplant renal dysfunction in marrow transplant patients. The wide interpatient variability in CsA concentration (Fig 3), the narrow therapeutic index of CsA, and the significant correlation between CsA concentration and renal dysfunction suggest that monitoring of trough CsA concentrations may be helpful in minimizing unnecessary renal toxicity, at least in marrow transplant recipients. Further studies are needed to determine whether CsA concentration correlates with prevention of graft-v-host disease. Co-administration of potentially nephrotoxic drugs during CsA therapy should be avoided or minimized if possible.

AB - CsA is a major contributing factor in the development of posttransplant renal dysfunction in marrow transplant patients. The wide interpatient variability in CsA concentration (Fig 3), the narrow therapeutic index of CsA, and the significant correlation between CsA concentration and renal dysfunction suggest that monitoring of trough CsA concentrations may be helpful in minimizing unnecessary renal toxicity, at least in marrow transplant recipients. Further studies are needed to determine whether CsA concentration correlates with prevention of graft-v-host disease. Co-administration of potentially nephrotoxic drugs during CsA therapy should be avoided or minimized if possible.

UR - http://www.scopus.com/inward/record.url?scp=0022358040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022358040&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 196

EP - 201

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 4 SUPPL. 1

ER -